Vitamin D Deficiency and Dysphagia: Muscle Function, Falls and Swallowing Safety
Vitamin D is widely recognised for its role in calcium metabolism and bone health, but its functions extend substantially into muscle physiology — making it directly relevant to dysphagia management. Vitamin D receptors are expressed in skeletal muscle fibres, and adequate vitamin D signalling is necessary for normal muscle protein synthesis, fast-twitch fibre preservation, and neuromuscular coordination. The muscles of swallowing — the tongue, pharyngeal constrictors, and laryngeal elevators — are no exception.
This article reviews the evidence for vitamin D deficiency as a risk factor for dysphagia and impaired swallowing muscle function, the link between vitamin D, sarcopenia, and falls, supplementation guidance, and monitoring in clinical and care settings.
Vitamin D and Muscle Physiology
Mechanisms of vitamin D action in muscle
Vitamin D exerts both genomic (through the vitamin D receptor in muscle cell nuclei) and non-genomic (rapid membrane signalling) effects on skeletal muscle:
-
Regulation of muscle protein synthesis: Vitamin D signalling through the nuclear receptor promotes the expression of proteins involved in muscle fibre anabolism, particularly type II (fast-twitch) fibres.
-
Calcium handling: Vitamin D influences the release of calcium from the sarcoplasmic reticulum — essential for muscle contraction. Low vitamin D impairs contraction efficiency.
-
Fibre type maintenance: Type II fast-twitch fibre atrophy is the hallmark of sarcopenia and is significantly accelerated by vitamin D deficiency. The swallowing musculature — particularly the geniohyoid and suprahyoid muscles — is predominantly composed of type II fibres.
-
Myopathy risk: Severe vitamin D deficiency causes a characteristic proximal myopathy with weakness and difficulty with functional movements. Subtle deficiency may produce subclinical weakness insufficient to cause overt myopathy but sufficient to worsen swallowing effort.
Karen Chan and colleagues at the HKU Swallowing Research Laboratory have published work on the nutritional determinants of swallowing muscle health, identifying vitamin D as one of several nutrients with biologically plausible roles in sarcopenic dysphagia pathogenesis.
Prevalence of Vitamin D Deficiency in Dysphagia Populations
Vitamin D deficiency is highly prevalent among the populations most affected by dysphagia:
- Older adults in residential care: Studies consistently report deficiency rates of 70–90% in care home residents, driven by reduced sun exposure, reduced dietary intake, and impaired cutaneous synthesis with ageing.
- Stroke survivors: Hospital admission, reduced mobility, and dietary disruption all contribute to post-stroke vitamin D deficiency. One systematic review found serum 25-hydroxyvitamin D levels < 50 nmol/L in 70–80% of acute stroke patients.
- Cancer patients with dysphagia: Head-and-neck cancer treatment — radiotherapy, surgery — is associated with reduced food intake and often inadequate vitamin D intake.
- Parkinson’s disease: Lower sunlight exposure (due to reduced outdoor activity), reduced dietary variety, and the disease’s own pathophysiological effects all contribute to a high prevalence of deficiency.
In Hong Kong specifically, despite subtropical climate, vitamin D deficiency is paradoxically common among older institutionalised adults due to indoor living, sunscreen use, and dietary patterns low in marine foods. This is relevant to local care home and hospital practice.
Vitamin D, Falls, and the Dysphagia Connection
Falls are the most commonly cited non-bone consequence of vitamin D deficiency, and the mechanism is primarily muscular: reduced type II fibre function impairs postural reflexes and balance recovery. The fall–dysphagia connection operates through several pathways:
- Fall → head injury → traumatic brain injury dysphagia: TBI is a recognised cause of neurogenic dysphagia.
- Fall → hip fracture → prolonged immobilisation → sarcopenic deconditioning → worsening sarcopenic dysphagia.
- Shared risk factor: Vitamin D deficiency predisposes to both sarcopenic dysphagia (directly) and falls (via muscle weakness), so both conditions may appear together in the same patient without one causing the other.
The NICE guideline CG62 (Falls in Older People) recommends vitamin D supplementation as a standard component of falls prevention in care home settings, which has relevance to dysphagia management programmes in the same settings.
Assessment and Interpretation of Vitamin D Status
Serum 25-hydroxyvitamin D (25-OHD)
The standard marker for vitamin D status is serum 25-hydroxyvitamin D (25-OHD), measured in nmol/L (SI) or ng/mL.
| 25-OHD level | Classification |
|---|---|
| < 25 nmol/L (< 10 ng/mL) | Severe deficiency |
| 25–50 nmol/L (10–20 ng/mL) | Deficiency |
| 50–75 nmol/L (20–30 ng/mL) | Insufficiency |
| > 75 nmol/L (> 30 ng/mL) | Sufficient |
| > 250 nmol/L (> 100 ng/mL) | Potential toxicity |
For muscle function and falls prevention, most evidence supports a target of > 75–100 nmol/L.
When to screen
All patients with sarcopenic dysphagia, older adults in care home settings, and post-stroke patients should be screened for vitamin D deficiency as a standard component of nutritional assessment.
Supplementation Guidance
Standard dosing for deficiency correction
| Indication | Recommended approach |
|---|---|
| Severe deficiency (< 25 nmol/L) | Loading dose: 50,000 IU cholecalciferol weekly × 8 weeks, then maintenance |
| Deficiency (25–50 nmol/L) | 800–1,000 IU daily cholecalciferol |
| Insufficiency (50–75 nmol/L) | 600–800 IU daily |
| Prevention in care home residents | 800 IU daily (NICE CG21 recommendation) |
Formulation for dysphagia
Vitamin D supplements are available in:
- Oral drops (liquid): Easiest to administer to dysphagia patients — can be added to food or liquid.
- Soft gel capsules: Require intact capsule swallowing; not suitable for most IDDSI Level 3–4 patients.
- Dissolving tablets (oro-dispersible): Dissolve on the tongue; appropriate for many dysphagia presentations if saliva production is adequate.
- Intramuscular injection: For patients who cannot reliably absorb oral vitamin D (malabsorption syndromes, unreliable oral intake).
Combined D + calcium supplementation
Vitamin D supplementation for bone health is often combined with calcium. However, for patients with dysphagia primarily being treated for muscle function rather than bone, calcium supplementation adds complexity without necessarily adding benefit. Discuss with the prescribing physician whether calcium co-supplementation is indicated.
Dietary Sources of Vitamin D in Texture-Modified Diets
Dietary vitamin D is found predominantly in marine foods:
| Source | Vitamin D per 100 g | IDDSI compatibility |
|---|---|---|
| Canned salmon | 500–600 IU | Level 4–5 |
| Canned sardines | 300–400 IU | Level 4–5 |
| Egg yolk | ~37 IU per yolk | Level 4 (blended in) |
| Fortified milk | 100 IU / 200 mL | Level 0–4 depending on thickening |
| Fortified yoghurt (smooth) | 50–80 IU / 200 g | Level 4 |
Dietary sources alone are generally insufficient to correct significant deficiency, particularly in older adults and care home residents. Supplementation is typically required alongside optimised dietary intake.
Monitoring
Following initiation of vitamin D supplementation:
- Recheck serum 25-OHD at 3 months.
- Adjust dose to achieve target level (>75 nmol/L for muscle function benefit).
- Annual maintenance checks thereafter.
- Monitor calcium and renal function if high-dose supplementation is used.
Key Takeaways
- Vitamin D deficiency impairs type II muscle fibre maintenance — directly affecting swallowing muscle strength.
- Deficiency is highly prevalent in older adults, care home residents, post-stroke patients, and Parkinson’s patients.
- Screen all sarcopenic dysphagia patients with serum 25-OHD; target > 75 nmol/L.
- Supplement with oral drops or oro-dispersible tablets for dysphagia patients; avoid capsules.
- Dietary sources (canned salmon, sardines, egg yolk, fortified milk) can contribute but rarely suffice alone.
References
- Cichero JAY et al. (2017). Development of International Terminology and Definitions for Texture-Modified Foods and Thickened Fluids Used in Dysphagia Management. Dysphagia. PMID 26315994
- IDDSI (2019). Complete IDDSI Framework. https://www.iddsi.org/framework
- American Speech-Language-Hearing Association. Adult Dysphagia. https://www.asha.org/practice-portal/clinical-topics/adult-dysphagia/
- NICE (2013, updated 2017). Intravenous fluid therapy in adults in hospital (CG162). https://www.nice.org.uk/guidance/cg162